Clinical Responses to Tarlatamab Among Patients with Pulmonary Carcinoid
{{output}}
Background: Pulmonary carcinoid (PC) is a rare, well-differentiated neuroendocrine tumor of the lung. In patients with metastatic disease, systemic therapies typically have low response rates, and long-term survival is poor. PC f... ...